China National Accord Medicines Corp Ltd
SZSE:000028
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
China National Accord Medicines Corp Ltd
SZSE:000028
|
CN |
|
G
|
GMP Property SOCIMI SA
MAD:YGMP
|
ES |
|
Haidilao International Holding Ltd
HKEX:6862
|
CN |
|
Tata Power Company Ltd
NSE:TATAPOWER
|
IN |
|
B
|
Banco Santander-Chile
SGO:BSANTANDER
|
CL |
|
Surya Toto Indonesia Tbk PT
IDX:TOTO
|
ID |
|
Horiba Ltd
TSE:6856
|
JP |
|
Amvis Holdings Inc
TSE:7071
|
JP |
Wall Street
Price Targets
Price Targets Summary
China National Accord Medicines Corp Ltd
According to Wall Street analysts, the average 1-year price target for China National Accord Medicines Corp Ltd is 26.25 CNY with a low forecast of 19.7 CNY and a high forecast of 33.74 CNY.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is China National Accord Medicines Corp Ltd's stock price target?
Price Target
26.25
CNY
According to Wall Street analysts, the average 1-year price target for China National Accord Medicines Corp Ltd is 26.25 CNY with a low forecast of 19.7 CNY and a high forecast of 33.74 CNY.
What is China National Accord Medicines Corp Ltd's Revenue forecast?
Projected CAGR
4%
For the last 13 years the compound annual growth rate for China National Accord Medicines Corp Ltd's revenue is 13%. The projected CAGR for the next 3 years is 4%.
What is China National Accord Medicines Corp Ltd's Operating Income forecast?
Projected CAGR
0%
For the last 13 years the compound annual growth rate for China National Accord Medicines Corp Ltd's operating income is 9%. The projected CAGR for the next 3 years is 0%.
What is China National Accord Medicines Corp Ltd's Net Income forecast?
Projected CAGR
23%
For the last 13 years the compound annual growth rate for China National Accord Medicines Corp Ltd's net income is 5%. The projected CAGR for the next 3 years is 23%.
